Merck and Moderna Launch Second Late-Stage Study of Keytruda and V940 Combination TherapyBy topmanagerDecember 11, 20230 Merck and Moderna have recently announced the initiation of a Phase 3 clinical trial to assess the efficacy of combining…
Merck & Co. and Eisai Report Keytruda Plus Lenvima Study in Endometrial CancerBy topmanagerDecember 8, 20230 Merck & Co. and Eisai recently announced the outcome of a Phase 3 study investigating the use of Keytruda plus…
